1,078 results found

Citing "policy and operational challenges" with the current 340B Administrative Dispute Resolution (ADR) Process, the US Department of Health and Human Services (HHS) has issued a new Proposed Rule...

On 30 October 2006 the Department of Health, in partnership with the NHS, the Association of British Pharmaceuticals Industry (ABPI) and the BioIndustry Association (BIA), released a revised model Clinical Trials Agreement (mCTA). The revised mCTA is designed to speed up the contracting process and ensure early initialisation of research.

Private equity's investments in healthcare have often struggled to meet expectations. Top-line growth and attractive exit multiples are elusive in a sector weighed down by legacy systems, labor costs, and regulatory...

To mark our 175th anniversary, James Bowen, a trainee patent attorney in our Chemistry & Life Sciences team, discusses the issue of food insecurity...

The rise of 3D printing in MedTech allows for custom-fit prosthetics, implants, and even personalized drugs. Patent considerations include protecting 3D printing files and addressing new legal standards for computer simulations. Siemens' personalized heart stent, enabled by 3D printing, exemplifies this innovation

The past year has been a defining one for the global chemical industry.

Rapid advancements in technology, evolving workforce expectations and an increasingly competitive environment are driving transformative change in the BioPharma and Life Sciences (BPLS) sector.

Our round-up has a good mix of case highs and the lows, from luxury goods companies taking brand protection seriously, as you might expect...

In an industry first, each cardboard crate of the new multipack will contain 3 alcoholic beers and 1 alcohol-free option.

2024 saw a significant increase in the total fines imposed in abuse of dominance cases compared to 2023, reversing a trend of decline in recent years.

The UK government has proposed amendments to the Health Bill that could introduce an MHRA licensing regime for medical devices used in aesthetic treatments. While no new requirements are in effect yet, these enabling provisions signal a shift toward greater regulatory oversight of the devices and technologies increasingly used in non-surgical cosmetic procedures, prompting providers to review their equipment governance and compliance frameworks.

Since the Trump Administration's start, its speak has been all about "removing the barriers to American leadership in artificial intelligence."

On 30 January 2020 the European Court of Justice ("ECJ") clarified for the first time the criteria governing whether so-called "pay-for-delay" agreements entered into between originator and generic

On 17 July 2024, King Charles III outlined the government's plans for the new Parliamentary session in the King's Speech at the state opening of Parliament.

On 6th April 2005 the European Commission published a communication entitled "Healthier, safer, more confident citizens: a Health and Consumer Protection Strategy" (the "Communication"). It sets out the Commission's proposed strategy in this area for 2007-13 and includes a proposal to establish a programme of community action in the fields of health and consumer protection.

On 16 July 2003, the European Commission published a proposal for a Regulation on nutrition and health claims (the "proposed Regulation"). The aim of the proposed Regulation is to ensure that consumers are better informed and to replace the different national provisions relating to such claims with common provisions at Community level. Under the proposed Regulation certain nutrition claims and health claims would be banned including health claims on beverages containing more than 1.2% by

On March 28, 2025, Michael Tappin KC, sitting as a deputy judge of the High Court, refused to grant AstraZeneca ("AZ") an interim injunction to restrain Glenmark from launching in the U.K...

The rise of personalised medicine brings IP challenges in patenting, trade marks, data protection and more. Here's what IP owners need to know.